By Michael Keane, BMBS, FANZCA and Shashikanth Manikappa, MD, DNB, FANZCA
February 21, 2019
Patient safety requires a well-informed debate about the rationale of large, randomized controlled trials (RCTs) and whether, by their very nature, they can adequately consider the unique physiology of every individual patient.
RCTs must be reproducible; the fundamental premise of any scientific experiment. In their day-to-day practice, clinicians must, therefore, be willing to reproduce the same treatment of individual patients’ physiology. If clinicians would treat individual patients (including physiological outliers) differently to that in which individual patients were treated in a trial, then that trial data becomes meaningless to their practice. Continue reading “Do Large Clinical Trials Adequately Consider Individual Patient Physiology? Debating The RELIEF Study”